POU2F2 and hepatocellular carcinoma: DEN administration induces mice to develop HCC, whose development course is similar to human HCC, by inducing hepatocyte DNA damage.[19] POU2F2 expression was identified in mouse liver as early as 5 months after DEN challenge, and then gradually increased in the following months (Figure 1C and Figure S1B,C, Supporting Information).